14 results
10-Q
2022 Q3
PRME
Prime Medicine Inc
14 Nov 22
Quarterly report
4:46pm
of directors to make, alter, amend or repeal our amended and restated by-laws; and
require supermajority votes of the holders of our common stock to amend
424B4
PRME
Prime Medicine Inc
21 Oct 22
Prospectus supplement with pricing info
4:47pm
amended and restated by-laws; and
require supermajority votes of the holders of our common stock to amend specified provisions of our third amended
S-1/A
kardq99mgl2ca
13 Oct 22
IPO registration (amended)
10:51am
S-1
7kb1gsnn83iy1
23 Sep 22
IPO registration
4:12pm
DRS/A
ro3u8plk
5 Aug 22
Draft registration statement (amended)
12:00am
DRS/A
jf5b2qm w31
6 May 22
Draft registration statement (amended)
12:00am
DRS/A
cms5c w0xj1q0
8 Apr 22
Draft registration statement (amended)
12:00am
DRS/A
az304 3a7tc7o507kcck
25 Mar 22
Draft registration statement (amended)
12:00am
DRS/A
1ixxea8fhrqhwoshn2
7 Mar 22
Draft registration statement (amended)
12:00am
DRS/A
96go3cj qz
4 Feb 22
Draft registration statement (amended)
12:00am
DRS
ljc7g zdhktq
20 Dec 21
Draft registration statement
12:00am
- Prev
- 1
- Next